A detailed history of Teton Advisors, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Teton Advisors, Inc. holds 7,900 shares of CDNA stock, worth $180,673. This represents 0.12% of its overall portfolio holdings.

Number of Shares
7,900
Holding current value
$180,673
% of portfolio
0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.41 - $33.99 $113,839 - $268,521
7,900 New
7,900 $246,000
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $184,410 - $357,480
-9,000 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$41.2 - $73.6 $20,600 - $36,800
-500 Reduced 5.26%
9,000 $409,000
Q3 2020

Nov 06, 2020

SELL
$30.88 - $37.94 $15,440 - $18,970
-500 Reduced 5.0%
9,500 $360,000
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $76,960 - $113,640
-4,000 Reduced 28.57%
10,000 $216,000
Q3 2017

Nov 01, 2017

BUY
$1.33 - $4.12 $18,620 - $57,680
14,000
14,000 $52,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.22B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Teton Advisors, Inc. Portfolio

Follow Teton Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teton Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Teton Advisors, Inc. with notifications on news.